A number of friends and family members of mine are currently taking statin drugs to lower their cholesterol. If it were true that cholesterol is unhealthy, then taking statin drugs to lower it would be a good thing – but scientific research has been clear for decades that lowering cholesterol will eventually lead to cancer, cardiovascular disease and many other degenerative diseases.
The public has been lied to about cholesterol for almost 100 years because the cholesterol mythology is extremely profitable for researchers, doctors, medical journals, drug producers and the food industry.
In this article you’ll learn that cholesterol does not clog your arteries or cause increased heart attacks and strokes, and that there’s no amount of cholesterol you can eat that is unhealthy. Also, you’ll learn that the real cause of high cholesterol and how to safely lower it in a way that will improve your health.
Helping people make more informed health decisions and preventing unnecessary suffering is what inspired me to write this article. I hope it puts the cholesterol deception to rest once and for all, saving you money, time and life.
Did You Know…
Dr. Uffe Ravnskov began the first chapter of his book Fat and Cholesterol are GOOD for you! by listing the following questions… Did you know…
- That cholesterol is not a deadly poison, but a substance vital to the cells of all mammals?
- That your body produces 3 to 4 times more cholesterol than you eat?
- That this production increases when you eat only small amounts of cholesterol and decreases when you eat larger amounts?
- That heart patients haven’t eaten more saturated fat than other people?
- That stroke patients have eaten less?
- That people with low cholesterol become just as atherosclerotic as people with high?
- That high cholesterol is not a risk factor for women?
- That many of the cholesterol-lowering drugs are dangerous to your health and may shorten your life?
- That most of these facts have been presented in scientific journals and books for decades but that proponents of the diet-heart hypothesis never tell them to the public?
- That the cholesterol campaign creates immense prosperity for researchers, doctors, medical journals, drug producers and the food industry?
FDA Reverses 50+ Year Position on Cholesterol
Many people aren’t even aware that in 2015, the FDA completely reversed their long-held position on cholesterol consumption. The ‘upper limit’ on cholesterol consumption was officially removed, meaning there’s no amount of dietary cholesterol you can consume that is bad for you.
Unforunately, many people still aren’t aware of this and the cholesterol myth continues at great cost to its victims. Let’s unravel some of these deceptions one at a time.
The Dangers of Low Cholesterol
In medical school, doctors are routinely taught by representatives of drug companies. This is why they learn profitable lies like high cholesterol is bad, and that lowering it with statins will improve patient health. In reality, scientific journals have been showing for decades that the opposite is true – having low cholesterol is a very dangerous situation with potentially fatal complications.
Statin drugs are commonly prescribed for cholesterol lowering, and they too can come with serious side effects, even aside from the dangers of reduced cholesterol itself. One of the side effects of statin drugs is they deplete the essential nutrient COQ10, which is important for cardiovascular and overall health. Statins also increase the risk of Type II diabetes.
But that’s enough about statins for now – the purpose of this article is to understand cholesterol. Let’s look at some evidence of what happens when the body doesn’t have adequate cholesterol.
- Low cholesterol causes impaired memory
- Low cholesterol doubles your chances of contracting HIV and AIDS
- Low cholesterol causes increased aggressive behavior and suicide
- Low cholesterol causes increased mortality from cardiovascular disease
- Low cholesterol causes increased mortality from stroke and cancer
The Benefits of High Cholesterol
Cholesterol is a substance with numerous beneficial uses in the body. It is so critical for health that every cell in the body has the ability to synthesize cholesterol. Understanding some of the benefits of having high cholesterol paints a clear picture of the true nature of this versatile, protective substance. Below are some of the benefits of high cholesterol.
- High cholesterol increases muscle and strength gain from exercise
- High cholesterol reduces your risk of infection
- High cholesterol protects against various poisons and environmental chemicals
- High cholesterol enhances the immune system
- High cholesterol increases lifespan
Cholesterol Doesn’t Clog Your Arteries
Cholesterol doesn’t increase your risk of heart disease, heart attack and stroke, wrote Dr. Dwight Lundell wrote in his book The Great Cholesterol Lie. This is because cholesterol is vital for human health and consuming it does not contribute to the clogging of arteries (atherosclerosis). Let’s look at some evidence for this.
The first study on cholesterol and atherosclerosis was published in 1936 by pathologist Kurt Lande and the biochemist Warren Sperry at New York University. The team of scientists found no association between the amount of cholesterol in the blood and the degree of atherosclerosis. People with low cholesterol were just as atherosclerotic as people with high cholesterol. In age-group after age group, the findings turned up the same, showing no association between concentration of cholesterol in the blood and atherosclerosis.
More studies have come to the same conclusion, like one by Dr. J.C. Paterson from London, Ontario, Canada, who for many years studied 800 war veterans and found that patients with low cholesterol were just as atherosclerotic as patients with high cholesterol. 
These and many other similar studies are either dismissed or never reported by the mainstream because they contradict the profitable yet mistaken mainstream ideology that ‘cholesterol clogs arteries.’ Another ignored line of research has been revealing for decades the true cause of atherosclerosis.
PUFA: The Real Cause of Clogged Arteries
A varnish is a transparent, hard, protective substance brushed onto wood which offers a protective, glossy finish. Until the advent of cheap varnishes derived from petrochemicals, linseed oil was most commonly used. The reason Linseed oil makes a good varnish is because – due to its unsaturation – it will harden extremely thoroughly in the presence of oxygen.
Linseed oil varnish is derived from flax seeds – and today flax seed oil is sold in stores as a health food.
Just as linseed oil applied to wood hardens as it reacts with oxygen from the surrounding air, linseed oil (and other polyunsaturated fatty acids) in the oxygen-rich bloodstream harden on the interior surfaces of arteries. This makes intuitive sense, and it’s also backed by a number of scientific studies.
In 2003, researchers from the United Kingdom studied the composition of human aortic plaques to see what they were made of. “Positive associations were found between serum and plaque ω6 (omega-6) and ω3 (omega-3) polyunsaturated fatty acids…”, which means they found a direct association between the amount of unsaturated fatty acids in the blood and the amount of arterial plaque. They also reported “No associations were found with saturated fatty acids,” which means that saturated fats like butter, coconut oil, beef fat, lamb fat and chocolate fat are all safe dietary fat choices for those looking to keep their arteries free from plaque. The study concluded “These findings imply a direct influence of dietary polyunsaturated fatty acids on aortic plaque formation and suggest that current trends favoring increased intake of polyunsaturated fatty acids should be reconsidered.”
Another study validating this finding was conducted by Dariush Mozaffarian and his colleagues from the Channing Laboratory at Harvard University, who sought to determine the effects of saturated vs unsaturated fat on the progression of atherosclerosis. The scientists asked elderly women with heart disease the type of food they had eaten, and found that atherosclerosis in those who had eaten the smallest amounts of saturated fat and the largest amounts of unsaturated polyunsaturated fats had worsened the most.
Now that we understand it’s polyunsaturated fats omega-3 and omega-6 that clog arteries, let’s dig a little deeper to understand how it works. To the extent that a fat is unsaturated, it is increasingly reactive. Conversely, saturated fats are protective because they are not vulnerable to free radical reactions.
When you consume a meal of unsaturated fats, the free fatty acids will enter your bloodstream – and these highly unstable fat molecules will begin reacting with oxygen. The oxidation and hardening of unsaturated fatty acids are catalyzed primarily by the presence of iron in the blood.
Age spots, also known as liver spots or lipofuscin, are also caused by the reaction between PUFA and iron. According to Dr. Ray Peat. “Age pigment is the brown material that forms spots on aging skin, and that accumulates in the lens of the eye forming cataracts, and in blood vessels causing hardening of the arteries, and in the heart and brain and other organs, causing their functions to deteriorate with age. It is made up of oxidized unsaturated oils with iron.”
While small amounts of iron are required for health, in excess it is toxic like all heavy metals. The typical western diet has more than enough iron, which is why foods like milk – which is almost entirely absent of iron, because the mother protects the baby by filtering it from the milk – are important, safe and nourishing. Both age spots and hardening of the arteries can be prevented by reducing your consumption of both unsaturated oils and iron in the diet.
Summary: Just as linseed oil brushed onto a piece of wood hardens through the process of oxidation, oxidized ‘essential’ unsaturated fatty acids cause hardening of the arteries.
Hypothyroidism: The Real Cause of High Cholesterol
It is clear now that having high cholesterol is not a threat to your health and that it even offers health benefits that can extend your lifespan. Although the high cholesterol itself is not a health concern, when somebody has very high cholesterol, something is happening inside the body that’s preventing the optimal use of cholesterol.
Since 1935 (or earlier), it has been known that low levels of thyroid hormone, also known as hypothyroidism, causes blood levels of cholesterol to rise above normal.
Normally, thyroid hormone would convert cholesterol into the protective, youth-associated hormones of the body like pregnenolone, testosterone, DHEA and progesterone. However, without adequate thyroid hormone, cholesterol levels in the blood will rise because it isn’t being used for this purpose. Thyroid hormone is a mirror image of total cholesterol; as thyroid goes up, cholesterol goes down, and as thyroid goes down, cholesterol goes up. “The thyroid hormone is required for using and eliminating cholesterol, so cholesterol is likely to be raised by anything which blocks the thyroid function,” wrote Dr. Raymond Peat.
Supplementation with a dessicated thyroid supplement (dry powdered thyroid gland pressed into a tablet) can be used to significantly benefit your health by permitting the conversion of cholesterol into the valuable, youth-associated hormones pregnenolone, testosterone, DHEA and progesterone.
Quotes About Cholesterol
“People with high cholesterol live the longest. This statement seems so incredible that it takes a long time to clear one´s brainwashed mind to fully understand its importance. Yet the fact that people with high cholesterol live the longest emerges clearly from many scientific papers. Consider the finding of Dr. Harlan Krumholz of the Department of Cardiovascular Medicine at Yale University, who reported in 1994 that old people with low cholesterol died twice as often from a heart attack as did old people with a high cholesterol.1 Supporters of the cholesterol campaign consistently ignore his observation, or consider it as a rare exception, produced by chance among a huge number of studies finding the opposite.”
– Dr. Uffe Ravnskov, Fat and Cholesterol are GOOD for you!
“A study that included 100,000 healthy participants in San Francisco over a fifteen-year period found that those with low cholesterol values were much more likely to be admitted to hospitals with infectious diseases.”
― Jonny Bowden, The Great Cholesterol Myth
“If you’re afraid of butter, use cream.”
― Julia Child
“Several serious medical studies and entire referenced books show that lowering cholesterol with medications did NOT reduce the number of deaths by stroke nor the amount of sickness, including heart attacks and (Atkins, Herbert, TW, Suurbula, Ravnskov, Smith). In addition, some commonly prescribed cholesterol-lowering drugs actually lowered the good HDL cholesterol as well (Johansson), putting you at higher risk of an early heart attack.”
― Dr. Sherry Rogers
“One recent study performed by the American Medical Association and published in the _Archives of Internal Medicine_ in January 2012 demonstrated an astounding 48 percent increased risk of diabetes among women taking statin medications.
This study involved big numbers — more than one hundred sixty thousand postmenopausal women — making it hard to ignore its significance and gravity. Recognizing that type 2 diabetes is a powerful risk factor for Alzheimer’s disease, a relationship between statin drugs and cognitive decline or cognitive dysfunction is certainly understandable.
― David Perlmutter, M.D., Grain Brain”
“Nothing could be further from the truth than the myth that if we lower our cholesterol levels we might have a greater chance of living longer and healthier lives. In a recent report appearing in the prestigious medical journal the Lancet, researchers from the Netherlands studied 724 elderly individuals whose average age was eighty-nine years and followed them for ten years. What they found was truly extraordinary.
During the study, 642 participants died. Each thirty-nine-point increase in total cholesterol corresponded to a 15 percent decrease in mortality risk. In the study, there was absolutely no difference in the risk of dying from coronary artery disease between the high- versus low-cholesterol groups, which is incredible when you consider the number of elderly folks who are taking powerful cholesterol-lowering drugs. Other common causes of death in the elderly were found to be dramatically associated with lower cholesterol. The authors reported: ‘Mortality from cancer and infection was significantly lower among the participants in the highest total cholesterol category than in the other categories, which largely explains the lower all-cause mortality in this category.’ In other words, people with the highest total cholesterol were less likely to die from cancer and infections — common fatal illnesses in older folks — than those with the lowest cholesterol levels. In fact, when you compare the lowest- and highest-cholesterol groups, the risk of dying during the study was reduced by a breathtaking 48 percent in those who had the highest cholesterol. High cholesterol can extend longevity.
― David Perlmutter, M.D., Grain Brain”
- Learn about Red Light Therapy
- Tinker, B. (2015). Cholesterol in food not a concern, report says. CNN. [Online]. Available: http://www.cnn.com/2015/02/19/health/dietary-guidelines [March 1, 2017].
- Larsen S, et al. Simvastatin Effects on Skeletal Muscle – Relation to Decreased Mitochondrial Function and Glucose Intolerance. J Am Coll Cardiol. 2013;61(1):44-53.
- Passi S, et al. Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA. Biofactors 2003;18(1-4):113-24.
- Meta-Analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Pubmed Health. 2013.
- Singh-manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG. Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study. Arterioscler Thromb Vasc Biol. 2008;28(8):1556-62.
- Huang X, Auinger P, Eberly S, et al. Serum cholesterol and the progression of Parkinson’s disease: results from DATATOP. PLoS ONE. 2011;6(8):e22854.
- Claxton AJ et al. J Acquir Immune Defic Syndr Hum Retrovirol 17, 51-7, 1998.
- Engelberg H. Low serum cholesterol and suicide. Lancet. 1992;339(8795):727-9.
- Boscarino JA, Erlich PM, Hoffman SN. Low serum cholesterol and external-cause mortality: potential implications for research and surveillance. J Psychiatr Res. 2009;43(9):848-54.
- Hawthon K, Cowen P, Owens D, Bond A, Elliott M. Low serum cholesterol and suicide. Br J Psychiatry. 1993;162:818-25.
- Ellison LF, Howard MI. Low serum cholesterol concentration and risk of suicide. Epidemiology. 2001. 12(2); 168-172.
- Horwich TB, Hamilton MA, Maclellan WR, Fonarow GC. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail. 2002;8(4):216-24.
- Bae JM, Yang YJ, Li ZM, Ahn YO. Low cholesterol is associated with mortality from cardiovascular diseases: a dynamic cohort study in Korean adults. J Korean Med Sci. 2012;27(1):58-63.
- Froom P, Kristal-boneh E, Melamed S, Harari G, Benbassat J, Ribak J. Serum total cholesterol and cardiovascular mortality in Israeli males: the CORDIS Study. Cardiovascular Occupational Risk Factor Determination in Israeli Industry. Isr Med Assoc J. 2000;2(9):668-71.
- Ravnskov U, Diamond DM, Hama R, et al. Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ Open. 2016;6(6):e010401.
- Knekt P, Reunanen A, Aromaa A, Heliövaara M, Hakulinen T, Hakama M. Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J Clin Epidemiol. 1988;41(6):519-30.
- Nago N, Ishikawa S, Goto T, Kayaba K. Low cholesterol is associated with mortality from stroke, heart disease, and cancer: the Jichi Medical School Cohort Study. J Epidemiol. 2011;21(1):67-74.
- Behar S, Graff E, Reicher-reiss H, et al. Low total cholesterol is associated with high total mortality in patients with coronary heart disease. The Bezafibrate Infarction Prevention (BIP) Study Group. Eur Heart J. 1997;18(1):52-9.
- Eichholzer M, Stähelin HB, Gutzwiller F, Lüdin E, Bernasconi F. Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study. Am J Clin Nutr. 2000;71(2):569-74.
- Riechman SE. Cholesterol and Skeletal Muscle Health. Texas A&M. 2009.
- Elias ER, et al. Am J Med Genet 68, 305-10, 1997.
- Tierney E, et al. Am J Med Genet Part B. 141B, 666-8, 2006.
- Aneja A & Tierney E. Int Rev Psychiatry 20, 165-70, 2008.
- Flegel WA, et al. Infect Immun 57, 2237-45, 1989.
- Flegel WA, et al. Infect Immun 61, 5140-6, 1993.
- Netea MG, et al. J Clin Invest 97, 1366-72, 1996.
- Krumholz HM and others. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. Journal of the American Medical Association 272, 1335-1340, 1990.
- Lane KE, Sperry WM. Arch Pathol. 22, 301-312, 1936.
- Paterson JC, et al. Circulation. 27, 229-236, 1963.
- Felton CV, Crook D, Davies MJ, Oliver MF. Dietary polyunsaturated fatty acids and composition of human aortic plaques. Lancet. 1994;344(8931):1195-6.
- Robb-Nicholson C. What’s the beef with red meat? Harvard Health Publishing.
- Pandey KB, Rizvi SI. Biomarkers of oxidative stress in red blood cells. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155(2):131-6.
- O’brien T, Katz K, Hodge D, Nguyen TT, Kottke BA, Hay ID. The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E. Clin Endocrinol (Oxf). 1997;46(1):17-20.
- Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-34.
- Turner KB, Steiner A. A LONG TERM STUDY OF THE VARIATION OF SERUM CHOLESTEROL IN MAN. J Clin Invest. 1939;18(1):45-9.
- Feld S, Dickey RA. An Association Between Varying Degrees of Hypothyroidism and Hypercholesterolemia in Women: The Thyroid-Cholesterol Connection. Prev Cardiol. 2001;4(4):179-182.
- Oribe H. [Clinical studies on lipid metabolism in hyperthyroidism and hypothyroidism–evaluation of serum apolipoprotein levels before and after treatment]. Nihon Naibunpi Gakkai Zasshi. 1989;65(8):781-93.
- Muls E, Blaton V, Rosseneu M, Lesaffre E, Lamberigts G, De moor P. Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment. J Clin Endocrinol Metab. 1982;55(3):459-64.
- Kung AW, Pang RW, Lauder I, Lam KS, Janus ED. Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism. Clin Chem. 1995;41(2):226-31.
- Diekman MJ, Anghelescu N, Endert E, Bakker O, Wiersinga WM. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes. J Clin Endocrinol Metab. 2000;85(5):1857-62.
- Meier C, Staub JJ, Roth CB, et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab. 2001;86(10):4860-6.
- Iqbal A, Jorde R, Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study. J Intern Med. 2006;260(1):53-61.
- Kung AW, Pang RW, Janus ED. Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endocrinol (Oxf). 1995;43(4):445-9.
- Mikhail GS, Alshammari SM, Alenezi MY, Mansour M, Khalil NA. Increased atherogenic low-density lipoprotein cholesterol in untreated subclinical hypothyroidism. Endocr Pract. 2008;14(5):570-5.
- Danese MD, Ladenson PW, Meinert CL, Powe NR. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab. 2000;85(9):2993-3001.
- Shin DJ, Osborne TF. Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element-Binding Protein-2 (SREBP-2). J Biol Chem. 2003;278(36):34114-8.
- Thompson GR, Soutar AK, Spengel FA, Jadhav A, Gavigan SJ, Myant NB. Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci USA. 1981;78(4):2591-5.
- Pugsley LI. The effect of thyrotropic hormone upon serum cholesterol. Biochem J. 1935;29(3):513-6.
- Jung CH, Sung KC, Shin HS, et al. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Korean J Intern Med. 2003;18(3):146-53.
- Luboshitzky R, Aviv A, Herer P, Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid. 2002;12(5):421-5.
- Pesić M, Antić S, Kocić R, Radojković D, Radenković S. [Cardiovascular risk factors in patients with subclinical hypothyroidism]. Vojnosanit Pregl. 2007;64(11):749-52.
- Walsh JP, Bremner AP, Bulsara MK, et al. Thyroid dysfunction and serum lipids: a community-based study. Clin Endocrinol (Oxf). 2005;63(6):670-5.
- Serter R, Demirbas B, Korukluoglu B, Culha C, Cakal E, Aral Y. The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism. J Endocrinol Invest. 2004;27(10):897-903.
- Milionis HJ, Tambaki AP, Kanioglou CN, Elisaf MS, Tselepis AD, Tsatsoulis A. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect. Thyroid. 2005;15(5):455-60.
- Arinzon Z, Zuta A, Peisakh A, Feldman J, Berner Y. Evaluation response and effectiveness of thyroid hormone replacement treatment on lipid profile and function in elderly patients with subclinical hypothyroidism. Arch Gerontol Geriatr. 2007;44(1):13-9.
- Miura S, Iitaka M, Yoshimura H, et al. Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy. Intern Med. 1994;33(7):413-7.
- Dzugan SA, Arnold smith R. Hypercholesterolemia treatment: a new hypothesis or just an accident?. Med Hypotheses. 2002;59(6):751-6.
- Althaus BU, Staub JJ, Ryff-de lèche A, Oberhänsli A, Stähelin HB. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol (Oxf). 1988;28(2):157-63.
- Thorell B, Svärdsudd K. Myocardial infarction risk factors and well-being among 50-year-old women before and after the menopause. The population study “50-year-old people in Kungsör”. Scand J Prim Health Care. 1993;11(2):141-6.
- Canaris, G.J., et al. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000 Feb 28;160(4):526-34.
- Mozaffarian D, Rimm EB, Herrington DM. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr. 2004;80(5):1175-84.